At The Medicine Shoppe® Pharmacies, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
RA Drugs May Prevent Early Death
Rheumatoid arthritis not only affects your joints, but also other organs throughout the body. When other organs are affected, patients may be faced with serious problems, even death. One type of drug may lower this risk.
RA Patients Did Well with Specialty Help
Controlling the pain and swelling of rheumatoid arthritis is no easy task. As such, treating the disease requires a specialist. A recent study suggests that patients should see a specialist as soon as possible.
Cell Phones Helped Slow RA
Cell phones have dramatically changed how we live our lives, from the way we communicate to how we organize our schedules. Now, it looks like cell phones may help arthritis patients stick to their treatment plans.
Left Out of Latest RA Treatments
Over the past decade, advances in the treatment of rheumatoid arthritis have made it easier for patients to live with this painful condition. Unfortunately, some patients may not have access to the newest treatments.
Back Pain: Arthritis Within Arthritis
Inflammation is the reason patients with rheumatoid arthritis develop swollen and painful joints. But inflammation is not unique to rheumatoid arthritis; it is also behind other painful joint conditions.
Savings From Slowing RA
Living with a chronic disease like rheumatoid arthritis can be expensive. Arthritis patients live years battling their painful condition with drugs and other treatments.
Different Drugs, Same Death Rates
When it comes to treating rheumatoid arthritis, there are a number of drugs that can be used. Each drug works differently and has different risks. Do these differences also mean different death rates?
FDA Approves Xeljanz for RA
When the standard drug treatment for rheumatoid arthritis is not working for a patient, it may be time to move on to another treatment. Now there is a new drug option for patients who need to make that switch.
FDA Approves Xeljanz For Rheumatoid Arthritis
The US Food and Drug Administration approved Xeljanz ( tofacitinib ) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate .
Heavy and Smoking: An RA Double-Whammy
Both smoking and being overweight can take a huge toll on your body. Combine the two together and you might be in store for serious health problems, particularly arthritis.